A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs
Clinical trial NCT05459844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05459844
- Sponsor
- Sinotau Pharmaceutical Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2024-06-26
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.